Are you Dr. Gershony?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 25 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2540 East St
Concord, CA 94520Phone+1 925-408-7252Fax+1 510-601-0433
Summary
- Dr. Gary Gershony, MD is a cardiologist in Concord, California. He is currently licensed to practice medicine in California, Oklahoma, and Georgia. He is affiliated with John Muir Medical Center, Concord and John Muir Medical Center, Walnut Creek.
Education & Training
- University of Toronto Faculty of MedicineClass of 1979
- Emory University School of MedicineFellowship, Interventional Cardiology
Certifications & Licensure
- CA State Medical License 1982 - 2026
- OK State Medical License 1989 - 1994
- GA State Medical License 1985 - 1987
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Valvuloplasty Scoring Balloon Catheter First-in-Man Study Start of enrollment: 2012 Jun 01
- ABSORB III Randomized Controlled Trial (RCT) Start of enrollment: 2012 Dec 01
Publications & Presentations
PubMed
- 22 citationsInhibition of neo-intimal hyperplasia in porcine coronary arteries utilizing a novel paclitaxel-coated scoring balloon catheter.Bodo Cremers, Stephanie Schmitmeier, Yvonne P. Clever, Gary Gershony, Ulrich Speck
Catheterization and Cardiovascular Interventions. 2014-12-01 - 27 citationsA novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: Results from the multi-center randomized controlled PATENT-C first in human trial.Bruno Scheller, Tobias Fontaine, Norman Mangner, Stefan Hoffmann, Klaus Bonaventura
Catheterization and Cardiovascular Interventions. 2016-07-01 - 93 citationsRisk factors, time course and treatment effect for restenosis after successful percutaneous transluminal coronary angioplasty of chronic total occlusion.Stephen G. Ellis, Richard E. Shaw, Gary Gershony, Ronald Thomas, Gary S. Roubin
The American Journal of Cardiology. 1989-04-15
Professional Memberships
- Fellow